Svetlana Dey, Director at Bluejay Diagnostics, Inc. (BJDX), bought 12,500 shares at $2.00 ($25K) on 2026-03-14, disclosed to the SEC on 2026-05-18.
Director Svetlana Dey purchased $25,000 of BJDX at $2.00, signaling confidence in the medical device company despite recent price declines. This buy occurs alongside a cluster of three other insider purchases in the last 30 days, potentially indicating a bottoming sentiment.
BJDX is trading at $1.66, down 38.29% over the last 90 days and 76.82% over the past year, currently sitting at its 52-week low.
Three other insiders bought shares in the last 30 days, creating a buying cluster that could signal a turnaround in the stock's momentum.
The stock carries a short interest of 2.21% of the float, which could lead to volatility if the price begins to recover.
Clearly above the average filing.
| Filing → |